Clinical Management of Primary Hypertension in Adults (NICE Guideline)

Summary of NICE guidance on high blood pressure.

 Download a pdf version of the above chart.

 

Measurement

  • If BP ≥140/90mmHg, take a second reading; if considerably different, take a third. Record the lower of the last two measurements as clinic BP.
  • Take a supine or seated reading in patients with symptoms of postural hypotension, followed by a reading after ≥1 min standing.
  • If clinic BP is ≥140/90mmHg, offer ambulatory blood pressure monitoring (ABPM) to confirm diagnosis.
  • If patient is unable to tolerate ABPM, offer home blood pressure monitoring (HBPM).
  • If severe hypertension, consider starting treatment immediately without waiting for results of ABPM or HBPM.
  • Measure BP on both of patient’s arms, if difference is >20mmHg repeat the measurement and if it remains >20mmHg use the arm with the higher reading for future measurements.
  • While waiting for ABPM or HBPM results, test for proteinuria. Measure plasma glucose, electrolytes, creatinine, eGFR, serum total cholesterol and HDL-cholesterol. Arrange a 12-lead ECG. Assess for hypertensive retinopathy.
  • Estimate 10-year cardiovascular disease (CVD) risk in accordance with the NICE guideline on lipid modification.
  • If hypertension is not diagnosed, assess in 5 years or consider more frequently if clinic BP is close to 140/90mmHg.

ABPM

  • Take ≥2 measurements per hour during patient’s usual waking hours.
  • Use average value of ≥14 measurements to confirm diagnosis.

HBPM

  • For each BP recording, take two measurements ≥1 min apart whilst patient is seated.
  • Record BP twice daily, ideally in the morning and evening.
  • Record BP for ≥4 days, ideally 7 days.
  • Discard measurements on day 1 and use the average value of remaining measurements to confirm diagnosis.

Aims

  • To reduce clinic BP to <140/90mmHg or average ABPM/HBPM to <135/85mmHg in patients <80 years="" li="">
  • To reduce clinic BP to <150/90mmHg or average ABPM/HBPM to <145/85mmHg in patients ≥80 years.

Note: See Hypertension in Pregnancy (NICE CG 107) for advice on the management of hypertension in women of childbearing potential.

Clinic BP (mmHg)Average ABPM or HBPM (mmHg)Recommended Action
Stage 1 hypertension ≥140/90 and ≥135/85 Offer treatment to patients <80 years="" with="" 1="" of="" the="" following:="" target="" organ="" damage="" established="" cvd="" renal="" disease="" diabetes="" or="" a="" 10="" year="" risk="" 20="" td="">
Stage 2 hypertension ≥160/100 and ≥150/95 Offer treatment to patients of any age.
Severe hypertension systolic ≥180 or diastolic ≥110 Consider immediate treatment.

Lifestyle measures

  • Offer lifestyle advice to all patients undergoing assessment or treatment for hypertension.
  • Assess patients' diet and exercise patterns and encourage appropriate lifestyle changes.
  • Advise patients to:
    – Limit weekly alcohol intake.
    – Avoid excessive consumption of coffee and other caffeine-rich products.
    – Limit dietary sodium intake by reducing intake or substituting sodium salt.
  • Offer smoking cessation help and advice.
  • Encourage stress reduction.

Note: Calcium, magnesium or potassium supplements should not be offered as a method for reducing BP.

Treatment

  • Offer patients ≥80 years the same treatment as younger patients taking account of any co-morbidity and patient’s existing burden of drug use.
  • Offer patients with isolated systolic hypertension (systolic BP ≥160mmHg) the same treatment as patients with both raised systolic and diastolic BP.
  • Provide patients with appropriate guidance and material about the benefits of drugs and the unwanted side effects that may occur in order to help patients make informed choices.
  • Where possible, recommend treatment with drugs that can be taken once daily.
  • Prescribe generic preparations where these are appropriate and minimise cost.
  • Use clinic BP measurements to monitor response to treatment. Consider ABPM or HBPM as an adjunct in patients identified as having ‘white-coat effect’.

Refer to Treatment Algorithm at top of article

Note

  • β-blockers are not a preferred initial therapy but are an alternative in patients <55 years="" with="" an="" intolerance="" or="" contraindication="" to="" ace="" inhibitors="" angiotensin="" ii="" receptor="" antagonists="" women="" of="" childbearing="" potential="" if="" evidence="" increased="" sympathetic="" drive="" em="">
  • If therapy initiated with a β-blocker, add a calcium-channel blocker rather than a thiazide-like diuretic to reduce risk of diabetes.
  • In patients well controlled with a regimen that includes a conventional thiazide diuretic, there is no absolute need to replace the conventional thiazide diuretic with an alternative agent.
  • If calcium–channel blocker not suitable or not tolerated, offer thiazide-like diuretic.
  • Angiotensin II receptor antagonist preferred to ACE inhibitor in black patients of African/Caribbean descent.

Follow-up

  • Annual review – monitor BP, provide patients with support and discuss lifestyle, symptoms and medication.

Specialist referral

  • Consider in patients with signs and symptoms suggesting secondary cause of hypertension. Accelerated (malignant) hypertension or suspected phaeochromocytoma require immediate referral.
  • Consider in patients with symptoms of, or documented, postural hypotension (fall in systolic BP when standing of 20mmHg or more).
  • Consider in patients with unusual signs or symptoms or in those whose management depends critically on the accurate measurement of their BP.
  • Consider if <40 years="" and="" no="" evidence="" of="" target="" organ="" damage="" cvd="" renal="" disease="" or="" diabetes="" li="">

Adapted from: NICE Clinical Guideline 127 (August 2011) - Hypertension: clinical management of primary hypertension in adults (partially updates and replaces NICE Clinical Guideline 34).


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases